FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection to treat forehead wrinkles is set to rival Allergan’s Botox after U.S. regulators approved Evolus Inc’s cheaper treatment on Friday, sending its shares up about 5 percent after the bell. FILE PHOTO: A vial of Botox and a syringe are seen in Athens, Greece December 12, 2017. REUTERS/Costas Baltas REUTERS/Mike Segar… Read More »